Additional Patents Licensed for Use

(a) United States Patent Number U.S. 11,969,401 entitled •compositions and Methods for Treating or Limiting Development of Age-Related Macular Degeneration· issued on April 30, 2024 {ARIZONA Ref No. UA19-094); and

(b) United States Patent Number U.S. 9,173,862 entitled “Methods and Compositions for Treating and Identifying Compounds to Treat Age-Related Macular Degeneration” issued on November 3, 2015 (ARIZONA Ref No. UA0B-067); and

(c) United States Patent Number U.S. 9,861,600 “Methods and Compositions for Treating and Identifying Compounds to Treat Age-Related Macular Degeneration Treatment” issued on January 9, 2018 (ARIZONA Ref No. UA0B-067); and

(d) Australian Patent Number AU2009236078 entitled “Methods and Compositions for Treating and Identifying Compounds to Treat Age-Related Macular Degeneration” issued on June 19, 2014 (ARIZONA Ref No. UA0B-067); and

(e) European Patent Number EP2273988 entitled “Methods and Compositions for Treating and Identifying Compounds to Treat Age-Related Macular Degeneration” issued on September 9, 2015 and validated in France, Germany, Sweden, Switzerland, and United Kingdom on September 9, 2015 (ARIZONA Ref No. UA0B-067)